Clinical Discovery Program
The purpose of the Clinical Discovery Program is to rapidly translate and test novel diagnostic and therapeutic approaches from bench to bedside. This Program focuses primarily on technologies previously developed at CSB but also applies other new technologies as they are related to human biology. The primary fields of interest are currently in cancer dx, clinical imaging and systems analyses. Investigators in this program are practicing clinician scientists from Massachusetts General Hospital and collaborators from other Harvard Medical School teaching hospitals. The program is primarily funded through grants from NIH.
Case 5-2019: A Woman with Delusional Thinking and Paresthesia of the Right Hand. Reply.
Case 5-2019: A 48-Year-Old Woman with Delusional Thinking and Paresthesia of the Right Hand.
Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin.
2013-12-30: Mukesh G. Harisinghani, MD, has been promoted to Professor of Radiology, Harvard Medical School. Congratulations Mukesh!
2012-11-28: Sandeep Hedgire, MD receives the Cum Laude award for his education exhibit at the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America.
New Boston Museum of Science's Virtual Exhibit
features work of Drs. Weissleder and Harisinghani
on the design of a clinical trial to determine how iron-oxide nanoparticles could enhance a diagnostic image produced by an MRI machine to the extent that the spread of cancer could be accurately assessed.